Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neosporin Original Triple Antibiotic Ointment
- Development stage
- Phase 1
- Lead developer
- Johnson & Johnson Consumer Inc. (J&JCI)
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Neosporin Original Triple Antibiotic Ointment is a topical antibiotic combination product developed and manufactured by Johnson & Johnson. It contains three active ingredients: bacitracin zinc, neomycin sulfate, and polymyxin B sulfate, formulated in a petroleum jelly base. This combination provides broad-spectrum coverage against various gram-positive and gram-negative bacteria. Neomycin is an aminoglycoside that inhibits bacterial protein synthesis by binding to ribosomal RNA; polymyxin B increases bacterial cell membrane permeability by interacting with phospholipid components; and bacitracin interferes with bacterial cell wall synthesis. The product is primarily indicated for the prevention of infection in minor skin injuries, including cuts, scrapes, and burns. It is available over-the-counter and is widely recognized as a leading brand in topical wound care.
- Brand names
- Neosporin Original Triple Antibiotic OintmentNeosporin
- Other names
- Triple Antibiotic Ointmentbacitracin zinc + neomycin sulfate + polymyxin B sulfate
02
Targets
Bacterial RibosomeOM/IM (Gram-negative bacterial outer and cytoplasmic membranes)
Beyond the preview
Go deeper on Neosporin Original Triple Antibiotic Ointment.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neosporin Original Triple Antibiotic Ointment.